Browsing by Yonsei Author : Kim, Jin Seok

eperson profile image
Kim, Jin Seok [김진석]
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (55032033600)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 228

This table browses all dspace content
Issue DateTitleJournal Title
2022국내 Human Research Protection Program 도입 과정과 발전 방향에 대한 고찰 Journal of KAIRB
2022Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myelomaBRITISH JOURNAL OF HAEMATOLOGY
2022Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma SCIENTIFIC REPORTS
2022An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment THERAPEUTIC ADVANCES IN HEMATOLOGY
2022Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study CANCER RESEARCH AND TREATMENT
2022Management of immune thrombocytopenia: 2022 update of Korean experts recommendations BLOOD RESEARCH
2022Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features CURRENT PROBLEMS IN CANCER
2022Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea CURRENT PROBLEMS IN CANCER
2022Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2022Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients JOURNAL OF MOLECULAR DIAGNOSTICS
2021Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea BLOOD RESEARCH
2021Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter studyANNALS OF HEMATOLOGY
2021Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: a randomized phase 3 study BLOOD ADVANCES
2021다발골수종 및 관련 형질세포 질환의 조기 진단을 위한 선별 검사 Korean Journal of Medicine
2021국내 임상시험 및 대상자 보호프로그램 도입 현황과 안전관리체계에 대한 설문조사 연구 Journal of Korean association of IRB
2021Risk factors for neutropenic fever in non-Hodgkin's lymphoma patients with primary granulocyte colony-stimulating factor prophylaxis KOREAN JOURNAL OF INTERNAL MEDICINE
2021Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trialANNALS OF HEMATOLOGY
2021Daratumumab-Based Treatment for Immunoglobulin Light-Chain AmyloidosisNEW ENGLAND JOURNAL OF MEDICINE
2021Association between body image dissatisfaction and poor quality of life and depression among patients with hematopoietic stem cell transplantationSUPPORTIVE CARE IN CANCER
2021Clinical characteristics and prognostic factors of acquired haemophilia A in KoreaHAEMOPHILIA
2021Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphomaBONE MARROW TRANSPLANTATION
2021Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple MyelomaCLINICAL CANCER RESEARCH
2021Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trial ANNALS OF ONCOLOGY
2021Safety, pharmacokinetics, and pharmacodynamics of a next-generation subcutaneously administered coagulation factor IX variant, dalcinonacog alfa, in previously treated hemophilia B patientsJOURNAL OF THROMBOSIS AND HAEMOSTASIS
2021Updated recommendations for the treatment of venous thromboembolism BLOOD RESEARCH
2021Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
2021Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells EXPERIMENTAL HEMATOLOGY & ONCOLOGY
2021Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma KOREAN JOURNAL OF INTERNAL MEDICINE
2021Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study JOURNAL OF HEMATOLOGY & ONCOLOGY
2021Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myelomaSUPPORTIVE CARE IN CANCER
2021Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasoneINTERNATIONAL JOURNAL OF HEMATOLOGY
2021Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomasANNALS OF HEMATOLOGY
2021Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study KOREAN JOURNAL OF INTERNAL MEDICINE
2020Human herpesvirus 8-negative effusion-based lymphoma with indolent clinical behavior in an elderly patient: A case report and literature review ONCOLOGY LETTERS
2020Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX BLOOD CANCER JOURNAL
2020Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysisLEUKEMIA & LYMPHOMA
2020Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndromeTHROMBOSIS RESEARCH
2020Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database CANCER RESEARCH AND TREATMENT
2020Immunosuppressive role of CD11b + CD33 + HLA-DR - myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemia CANCER MEDICINE
2020Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphomaANNALS OF HEMATOLOGY
2020First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial CANCERS
2020Association between sexuality knowledge and sexual dysfunction in hematopoietic stem cell transplantation patients and their partnersPATIENT EDUCATION AND COUNSELING
2020Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)BONE MARROW TRANSPLANTATION
2020Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era SCIENTIFIC REPORTS
2020Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 studyINTERNATIONAL JOURNAL OF HEMATOLOGY
2020Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host diseaseANNALS OF HEMATOLOGY
2020ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2020Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study) AMERICAN JOURNAL OF HEMATOLOGY
2020Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial CANCER RESEARCH AND TREATMENT
2020PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH